Morgan Stanley Upgrades Helmerich & Payne to Equal-Weight, Raises Price Target to $55
Morgan Stanley analyst Connor Lynagh upgrades Helmerich & Payne (NYSE:HP) from Underweight to Equal-Weight and raises the price target from $48 to $55.
Domino’s Pizza Analyst Shows No ‘Pizza Fatigue,’ Turns Bullish On Stock
The lowered near-term expectations for Domino's Pizza Inc (NYSE: DPZ) have made the risk/reward attractive, according to BMO Capital Markets.
B. Riley Securities Upgrades Warrior Met Coal to Buy, Raises Price Target to $50
B. Riley Securities analyst Lucas Pipes upgrades Warrior Met Coal (NYSE:HCC) from Neutral to Buy and raises the price target from $48 to $50.
BMO Capital Upgrades Domino’s Pizza to Outperform
BMO Capital analyst Andrew Strelzik upgrades Domino's Pizza (NYSE:DPZ) from Market Perform to Outperform.
Wedbush Upgrades FuboTV to Outperform
Wedbush analyst Michael Pachter upgrades FuboTV (NYSE:FUBO) from Neutral to Outperform.
Evercore ISI Group Upgrades Spero Therapeutics to Outperform, Raises Price Target to $8
Evercore ISI Group analyst Josh Schimmer upgrades Spero Therapeutics (NASDAQ:SPRO) from In-Line to Outperform and raises the price target from $2 to $8.
Barclays Upgrades Arista Networks to Overweight
Barclays analyst Tim Long upgrades Arista Networks (NYSE:ANET) from Equal-Weight to Overweight.
UBS Upgrades Eli Lilly to Buy, Announces $363 Price Target
UBS analyst Navin Jacob upgrades Eli Lilly (NYSE:LLY) from Neutral to Buy and announces $363 price target.